Previous close | 10.98 |
Open | 10.99 |
Bid | 10.99 x 800 |
Ask | 11.00 x 1200 |
Day's range | 10.99 - 10.99 |
52-week range | 10.14 - 12.00 |
Volume | |
Avg. volume | 13,790 |
Market cap | 104.752M |
Beta (5Y monthly) | 0.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.44 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEW YORK, February 07, 2024--BlueRiver Acquisition Corp. (NYSE American: BLUA) (the "Company") announces that, as disclosed in the Company’s Current Report on Form 8-K filed on February 7, 2024 with the United States Securities and Exchange Commission, the Company received a letter from the NYSE American LLC ("NYSE American" or the "Exchange") on February 2, 2024, stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s Common Stock, Units and Righ
SAN ANTONIO, July 24, 2023--Spinal Stabilization Technologies ("SST" or the "Company"), a medical device company, and BlueRiver Acquisition Corp. ("BlueRiver") (NYSE AM: BLUA), a publicly traded special purpose acquisition company, have entered into a definitive business combination agreement. Upon the closing of the proposed transaction between SST and BlueRiver, the combined company will operate as Spinal Stabilization Technologies and be listed on an approved stock exchange.